810223C
Avanti
C12-NBD Glucosyl Ceramide
Avanti Research™ - A Croda Brand
别名:
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-β1-1′-sphingosine
产品名称
C12-NBD Glucosyl Ceramide, Avanti Research™ - A Croda Brand 810223C
方案
>99% (TLC)
表单
liquid
包装
pkg of 1 × 1 mL (810223C-250ug)
制造商/商品名称
Avanti Research™ - A Croda Brand 810223C
浓度
0.25 mg/mL (810223C-250ug)
运输
dry ice
储存温度
−20°C
应用
C12-NBD Glucosyl Ceramide is suitable for liposome preparation.
生化/生理作用
Glucosyl ceramide (GlcCer) is produced by GlcCer synthase from ceramide in the cytosolic membranes of Golgi. In the luminal Golgi membrane, GlcCer participates in the generation of glycosphingolipids.
包装
5 mL Amber Glass Screw Cap Vial (810223C-250ug)
法律信息
Avanti Research is a trademark of Avanti Polar Lipids, LLC
警示用语：
Danger
危险分类
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
靶器官
Central nervous system
WGK
WGK 3
法规信息
新产品
此项目有
The effects of chemically synthesized saposin C on glucosylceramide-beta-glucosidase
Yoneshige A, et al.
Clinical Biochemistry, 48(16-17), 1177-1180 (2015)
Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide
D?Angelo G, et al.
Nature, 449(7158), 62-62 (2007)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持